Coronary microvascular dysfunction (CMD) remains a significant cause of angina in patients with no obstructive coronary artery disease (ANOCA), with limited therapeutic options. Building on prior evidence from the double-blind and sham-controlled COSIRA trial, which demonstrated the efficacy of the coronary sinus (CS) reducer in improving angina and quality of life in patients with refractory angina secondary to obstructive CAD, Tryon et al. explored its potential role in CMD. ...
Cardiology
Advertisement
The CardioNerds and expert faculty Dr. Mark Drazner assess a woman's heart failure status.
The possibility of DCBs to rescue side branches during provisional coronary bifurcation stenting is appealing.
A study shows that humans, mice exposed to long-wavelength red light have lower rates of blood clots that cause stroke.
The study used SEER data of nearly 20,000 cases.
Estimates show that 2.2 million new cases of T2D and 1.2 million new cases of CVD are associated with sugary beverages.
According to several studies, anti-obesity medications demonstrate cardiovascular benefits beyond weight loss alone.
The CardioNerds and Dr. Mark Drazner discuss the right heart failure device placement with an elderly patient.
The CardioNerds and expert faculty Dr. Biykem Bozkurt discuss a 63-year-old patient with hypertension and T2D.
An electrocardiography (ECG)–based artificial intelligence risk estimator can predict the development of hypertension.
Dr. Amit Goyal details the first-in-human study of the Magenta Elevate system.
Advertisement
Expert Interviews on Cardiology
DocWire News delivers the latest medical industry news, giving health care professionals the curated content most relevant to their fields and practices.
Get the latest medical updates and insights straight to your inbox.
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.